EP3810279
A COMBINATION COMPRISING USING AN OLIGOPEPTIDIC COMPOUND AND ANTI-PD-1 OR PD-L1 ANTIBODY FOR USE IN TREATING NEOPLASTIC CONDITIONS
:
EP einkaleyfi: Þýðing ekki lögð inn:
19.6.2019:
13.9.2023:
19734322.1
:
18.6.2039
:
A COMBINATION COMPRISING USING AN OLIGOPEPTIDIC COMPOUND AND ANTI-PD-1 OR PD-L1 ANTIBODY FOR USE IN TREATING NEOPLASTIC CONDITIONS
19.6.2019
13.9.2023
:
Cytovation ASA:
Solheimsgaten 11, 5058 Bergen, NO
:
PRESTEGARDEN, Lars:
5058 Bergen, NO
:
201810058:
19.6.2018:
GB
:
EP2019066295:
19.6.2019
:
A61P 35/00, A61K 38/16, A61K 39/395